In conclusion, we propose a new ALK-BPI score as a prognostic tool that can be easily applied for ALK-positive lung cancer patients with BM in daily clinical practice, and that has at least the same, if not better, prognostic value as the Lung-molGPA system. Here, ALK is linked to lung carcinoma.